Skip to content
Roboearth – Lifestyle
Author:
Zomedica Corp.
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
March 18, 2026
Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
March 16, 2026
Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th “Fourth Friday at Four” Investor Webinar
March 10, 2026
←
Previous Page
1
2